Showing 1,561 - 1,580 results of 227,974 for search '(( 5 ((ppm decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 1561
  2. 1562

    Ischemia decreased bcl-2 content in rabbit SSM. by Qun Chen (313764)

    Published 2015
    “…<p><u>Panel A:</u> Western blotting shows that ischemia markedly decreased bcl-2 content in SSM isolated from rabbit heart compared to non-ischemic hearts. …”
  3. 1563
  4. 1564

    Forced expression of N-cadherin decreases cell survival. by Eric Haÿ (276921)

    Published 2013
    “…(B) N-cadherin silencing decreases osteoblast apoptosis. Flag cells were transfected with N-cadherin si-RNA or a non relevant si-RNA (si-NR) and treated with Wnt3a CM (15%) for 24 hours in serum deprived (1% FCS) medium and cell replication was determined. …”
  5. 1565

    Decreased HIF levels associated with hyperoxic cell state. by Julie M. Koeman (108185)

    Published 2008
    “…(C,D) Relative gene expression levels of HIF target genes in clear cell RCC (<i>n</i> = 10) and renal oncocytoma (<i>n</i> = 10) compared with non-diseased kidney (<i>n</i> = 12). For each gene, red indicates increased expression, blue decreased expression. …”
  6. 1566

    Human preterm infants diagnosed with IUGR have decreased Paneth cell counts compared to preterm non-IUGR control infants. by Camille M. Fung (844334)

    Published 2016
    “…Infants with a diagnosis of IUGR (n = 9) were compared to age-matched non-IUGR infants (n = 4). …”
  7. 1567
  8. 1568
  9. 1569
  10. 1570
  11. 1571

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  12. 1572
  13. 1573
  14. 1574

    Nur77 knockdown decreases cell viability and proliferation. by Alexa Tenga (2161780)

    Published 2016
    “…<p>(A) Daoy cells were transfected with 20 nM siNur77 or non-targeting control (NT), and cell viability was measured via the CellTiter-Glo assay every day for 3 days. …”
  15. 1575
  16. 1576
  17. 1577

    Absence or antagonism of TWEAK decreases CCL21 in AKI. by Ana B. Sanz (367453)

    Published 2013
    “…<p><b>A</b>) TWEAK deficiency or anti-TWEAK antibodies decrease kidney CCL21a mRNA in AKI at 24 h following injury. …”
  18. 1578
  19. 1579
  20. 1580

    Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

    Published 2024
    “…PG treatment in PUGKO mice decreases the expression of FOXA2 almost 33 times compared to the non-PG TX mice. …”